Andrew S Haynes

5PUBLICATIONS
16CO-AUTHORS
Infant and child healthMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

Sort by Publication Date:
|Sep 25, 2025
Oral Cephalexin Population Pharmacokinetics and Target Attainment Analysis in Infants 7-60 Days Old.

Andrew S Haynes, Zixuan Wei, Marc H Scheetz

|Apr 10, 2024
Cefadroxil and cephalexin pharmacokinetics and pharmacodynamics in children with musculoskeletal infections.

Andrew S Haynes, Zixuan Wei, Peter Anderson

|Jun 22, 2022
Cefadroxil Comparable to Cephalexin: Minimum Inhibitory Concentrations among Methicillin-Susceptible Staphylococcus aureus Isolates from Pediatric Musculoskeletal Infections.

Andrew S Haynes, Andrea Prinzi, Lori J Silveira

Pageof 1

Frequent Collaborators

2 joint publications

Marc H Scheetz

2 joint publications

Sonya Tang Girdwood

1 joint publications

Andrea Prinzi

1 joint publications

Alexander R Horswill

1 joint publications

Ronaldo Morales Junior

1 joint publications

Victor Amajor

1 joint publications

Kelli Paice

1 joint publications

Kathryn E Kyler

1 joint publications

H Rhodes Hambrick

1 joint publications

Kathryn E Pavia

Frequent Collaborators

2 joint publications

Marc H Scheetz

2 joint publications

Sonya Tang Girdwood

1 joint publications

Andrea Prinzi

1 joint publications

Alexander R Horswill

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Neutrophil Lifespan Extension with CLON-G and an <em>In Vitro</em> Spontaneous Death Assay
05:52

Neutrophil Lifespan Extension with CLON-G and an <em>In Vitro</em> Spontaneous Death Assay

Published on : May 12, 2023

2.0K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>K. pneumoniae</i>, <em>P. aeruginosa</em> or  <em>A. baumannii</em>
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>K. pneumoniae</i>, <em>P. aeruginosa</em> or <em>A. baumannii</em>

Published on : Jan 02, 2017

15.1K
X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on : Sep 11, 2011

14.4K
See more related videos

Top Related Videos

Neutrophil Lifespan Extension with CLON-G and an <em>In Vitro</em> Spontaneous Death Assay
05:52

Neutrophil Lifespan Extension with CLON-G and an <em>In Vitro</em> Spontaneous Death Assay

Published on : May 12, 2023

2.0K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>K. pneumoniae</i>, <em>P. aeruginosa</em> or  <em>A. baumannii</em>
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against <i>S. pneumoniae</i>, <i>H. influenzae</i>, <i>K. pneumoniae</i>, <em>P. aeruginosa</em> or <em>A. baumannii</em>

Published on : Jan 02, 2017

15.1K
X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on : Sep 11, 2011

14.4K
See more related videos